Compound record

(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-MBC)

No CAS · candidate list substance · endocrine disruption

SVHC Candidate ListEU monitoringendocrine disruption

Dossier Status Obligations Why Alternatives Changes Similar Sources

CAS Not assigned for this group record

Formula Not assigned for this group record

Molecular weight Not assigned for this group record

InChIKey No single-record key

Why monitored

Why this substance is monitored in the EU

(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-MBC) is currently surfaced as candidate list substance in the EU.

The current imported view anchors this substance in CandidateList. The live rationale focuses on Endocrine disrupting properties (Article 57(f) - human health), and this page is designed for fast status checks before deeper source review.

Reason

Endocrine disrupting properties (Article 57(f) - human health)

Open the cross-substance route for this rationale.

Rows behind the rationale

Imported framework context and legal signals

Framework	Status	Listed	Reason	Source
CandidateList	Candidate List substance	17 Jan 2022	Endocrine disrupting properties (Article 57(f) - human health)	Candidate List entry - (±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-MBC)